Abstract
Vaccination with a recombinant LCMV based vector expressing tumor-associated or viral antigens is a safe and versatile method to induce an immune response against tumors or viral infections. Here, we describe the generation of recombinant LCMV vectors in which the gene encoding the viral LCMV-GP was substituted with a gene of interest (vaccine antigen). This renders the vaccine vector propagation-incompetent while it preserves the property of eliciting a strong cytotoxic T cell response.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Zingernagel RM (2002) Lymphocytic choriomeningitis virus and immunology. Curr Top Microbiol Immunol 263:1–5
Zhou X, Ramachandran S, Mann M et al (2012) Role of lymphocytic choriomeningitis virus (LCMV) in understanding viral immunology: past, present and future. Viruses 4:2650–2669
Armstrong C, Lillie RD (1934) Experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1993 St. Louis encephalitis epidemic. Public Health Rep 49:1019–1027
Fischer SA, Graham MB, Kuehnert MJ et al (2006) Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 354:2235–2249
Bonthius DJ, Perlman S (2007) Congenital viral infections of the brain: lessons learned from lymphocytic choriomeningitis virus in the neonatal rat. PLoS Pathog 3, e149
Barton LL, Mets MB (2001) Congenital lymphocytic choriomeningitis virus infection: decade of rediscovery. Clin Infect Dis 33:370–374
Buchmeier MJ, Bowen MD, Peter CJ (2001) Arenaviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA, pp 1635–1668
Hangartner L, Zinkernagel RM, Hengartner H (2006) Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol 6:231–243
Lee KJ, Perez M, Pinschewer DD et al (2002) Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol 76:6393–6397
Pinschewer DD, Perez M, Sanchez AB et al (2003) Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc Natl Acad Sci U S A 100:7895–7900
Flatz L, Bergthaler A, de la Torre JC et al (2006) Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proc Natl Acad Sci U S A 103:4663–4668
Sanchez AB, de la Torre JC (2006) Rescue of the prototypic Arenavirus LCMV entirely from plasmid. Virology 350:370–380
Emonet SF, Garidou L, McGavern DB et al (2009) Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci U S A 106:3473–3478
Flatz L, Hegazy AN, Bergthaler A et al (2010) Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med 16:339–345
Matter M, Pavelic V, Pinschewer DD et al (2007) Decreased tumor surveillance after adoptive T-cell therapy. Cancer Res 67:7467–7476
Homann D, Teyton L, Oldstone MB (2001) Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med 7:913–919
Battegay M, Cooper S, Althage A et al (1991) Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods 3:191–198
Ortiz-Riano E, Cheng BY, de la Torre JC et al (2013) Arenavirus reverse genetics for vaccine development. J Gen Virol 94:1175–1188
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Ring, S., Flatz, L. (2016). Generation of Lymphocytic Choriomeningitis Virus Based Vaccine Vectors. In: Thomas, S. (eds) Vaccine Design. Methods in Molecular Biology, vol 1404. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-3389-1_24
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3389-1_24
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-3388-4
Online ISBN: 978-1-4939-3389-1
eBook Packages: Springer Protocols